Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells.
Morinaga S, Han Q, Mizuta K, Kang BM, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM.
Morinaga S, et al. Among authors: kimura h.
Anticancer Res. 2024 Nov;44(11):4773-4778. doi: 10.21873/anticanres.17303.
Anticancer Res. 2024.
PMID: 39477291